[The treatment of muscular dystrophy with the nucleoside-nucleotide mixture Laevadosine].
D002986:Clinical Trials as Topic; D003402:Creatine Kinase / Q000097:blood; D006801:Humans; D009136:Muscular Dystrophies / Q000188:drug therapy* / Q000201:enzymology; D009705:Nucleosides / Q000008:administration & dosage / Q000627:therapeutic use*; D009711:Nucleotides / Q000008:administration & dosage / Q000627:therapeutic use*; D010710:Phosphates / Q000378:metabolism; D010919:Placebos
D009705:Nucleosides; D009711:Nucleotides; D010710:Phosphates; D010919:Placebos; D003402:Creatine Kinase
Behandlung von Muskeldystrophien mit dem Nukleosid-Nukleotid-Gemisch Laevadosin.